Tenderwize
Back to tender search

Supply of Momelotinib product

Υπουργείο Υγείας·Λευκωσία, Cyprus·EUR 632.5k·Deadline Jul 23, 2026 · 6 days left·Open·Supplies
Original notice title

Cyprus – Antineoplastic agents – Προσφορά για την προμήθεια σκευάσματος Momelotinib

67/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

67 / 100

Complexity

38 / 100

Risk factors

The structured data shows estimatedValue.amount as 0 EUR at notice level, while the lot-level value is EUR 632,468 and...

Structured data flags the tender as EU-funded, but the XML notice contains FundingProgramCode: no-eu-funds.

Submission deadline in 6 days

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • EUR 632.5k estimated value
  • Supplies contract
  • 1 lot
  • Duration 24 MONTH
  • Supply of Momelotinib pharmaceutical product.
  • Supply contract for antineoplastic agents under CPV 33652100.
Show full summary

Open supply tender in Cyprus for Momelotinib (antineoplastic agent), led by the Ministry of Health. One lot is identified, with an estimated value of EUR 632,468 and a 24-month duration. Award is on lowest price only. Electronic submission is required. The notice and XML are available, but no procurement document text beyond the XML notice was provided, so document-based requirements cannot be fully assessed.

Risks

The structured data shows estimatedValue.amount as 0 EUR at notice level, while the lot-level value is EUR 632,468 and...

Structured data flags the tender as EU-funded, but the XML notice contains FundingProgramCode: no-eu-funds.

Submission deadline in 6 days

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Procedure type is open.
  • Contract duration is 24 months.

Administrative

  • Electronic submission is required.

Award Criteria

Lot 1

Price criterion: lowest price (weight not stated)

Buyer

Location

Λευκωσία, CYP

Identifier

1357

Activity

Health

Lots (1)

LOT-0001

Supply of Momelotinib product

Supply of Momelotinib, an antineoplastic agent, for Cyprus. This lot is for supplies and is identified in the structured data as LOT-0001. The lot value is EUR 632,468 and the duration is 24 months. The lot is in Cyprus (CY000).

SuppliesEU fundedElectronic submissionSME suitable

EUR 632.5k

Estimated value

Location

CY000, Cyprus

Duration

24 MONTH

Category

Antineoplastic agents

Award Criteria

Price

Deadline

Deadline Jul 23, 2026

Procurement Details

Publication date
28 cze 2026
Languages
Greek

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
442829-2026

Documents (2)

Similar tenders